Organigram Holdings Files 6-K, Reports Under Form 40-F

Ticker: OGI · Form: 6-K · Filed: Jul 24, 2024 · CIK: 1620737

Sentiment: neutral

Topics: reporting, sec-filing, compliance

TL;DR

Organigram filed a 6-K, looks like standard Canadian reporting under 40-F. No major news yet.

AI Summary

Organigram Holdings Inc. filed a Form 6-K on July 24, 2024, to report a news release. The filing indicates that Organigram is submitting its annual report under Form 40-F, which is typical for Canadian companies reporting to the SEC. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This filing confirms Organigram's compliance with SEC reporting requirements for Canadian issuers. It signals ongoing operations and adherence to regulatory standards.

Risk Assessment

Risk Level: low — The filing is a routine procedural report and does not contain new material information that would immediately impact risk.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is being submitted by Organigram Holdings Inc. to report information that it has made or is required to make public in Canada, filed or made public outside the United States, or filed or made public with a stock exchange on which its securities are traded. In this instance, it includes Exhibit 99.1, a news release.

Which annual report form is Organigram Holdings Inc. using for its SEC filings?

Organigram Holdings Inc. is indicating that it files its annual reports under cover of Form 40-F.

What is the principal executive office address for Organigram Holdings Inc.?

The address of the principal executive offices is 145 King Street West, Suite 1400, Toronto, Ontario, Canada M5H 1J8.

When was the company incorporated or formed?

The filing does not explicitly state the incorporation date, but it does mention a former company name change date of 20140926.

What is the SIC code for Organigram Holdings Inc.?

The Standard Industrial Classification (SIC) code for Organigram Holdings Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 188 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2024-07-24 17:06:57

Filing Documents

From the Filing

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month July 2024 Commission File Number 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F X Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) SUBMITTED HEREWITH Exhibits 99.1 News release dated July 24, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ORGANIGRAM HOLDINGS INC. s Beena Goldenberg Beena Goldenberg Chief Executive Officer Date July 24, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing